(Press-News.org) More than one-third of adults in the United States are obese, and some of these individuals undergo gastric bypass surgery to shed the extra pounds. A genome-wide association study published by Cell Press May 2nd in The American Journal of Human Genetics reveals that the amount of weight loss after this surgery can be predicted in part by a DNA sequence variation found on chromosome 15. The findings explain why the success of gastric bypass surgery varies so widely and could help clinicians identify those who would benefit the most from this type of surgery.
"Surgery is the most effective therapy for severe obesity, but these procedures are invasive, and not all patients get the same degree of benefit," says senior study author Lee Kaplan of Massachusetts General Hospital and Harvard Medical School. "If we can identify those patients who are likely to lose more weight after surgery from those who do less well, we could help steer patients towards the therapy that best suits them."
Individuals who undergo gastric bypass surgery lose on average about 35%–40% of their initial weight and keep most of this weight off. But the amount of weight lost by different patients varies by a factor of four, and it is not understood what causes this wide difference in response.
To identify specific genetic factors that might play a role, Kaplan and his team examined the genomes of more than 1,000 individuals undergoing gastric bypass surgery. They found that individuals with two copies of a specific variant on chromosome 15 lost on average about 39% of their body weight, whereas those without a copy of this variant lost less than 30% of their body weight. Moreover, the activity of the gene located closest to this variant also predicted weight loss.
"This is the first instance where a genome-wide search has identified genetic predictors of weight loss after gastric bypass surgery," Kaplan says. "Since the genes identified in this report have not previously been known to be involved with body-weight regulation and obesity, their identification may suggest new approaches that could be used to develop novel therapies for obesity, diabetes, and related metabolic disorders."
INFORMATION:
The American Journal of Human Genetics, Hatoum et al.: "Weight loss after gastric bypass is associated with a variant at 15q26.1."
Genetic factor predicts success of weight-loss surgery
2013-05-02
ELSE PRESS RELEASES FROM THIS DATE:
Kids with brains that under-react to painful images
2013-05-02
When children with conduct problems see images of others in pain, key parts of their brains don't react in the way they do in most people. This pattern of reduced brain activity upon witnessing pain may serve as a neurobiological risk factor for later adult psychopathy, say researchers who report their findings in the Cell Press journal Current Biology on May 2.
That's not to say that all children with conduct problems are the same, or that all children showing this brain pattern in young life will become psychopaths. The researchers emphasize that many children with ...
Bonding with your virtual self may alter your actual perceptions
2013-05-02
When people create and modify their virtual reality avatars, the hardships faced by their alter egos can influence how they perceive virtual environments, according to researchers.
A group of students who saw that a backpack was attached to an avatar that they had created overestimated the heights of virtual hills, just as people in real life tend to overestimate heights and distances while carrying extra weight, according to Sangseok You, a doctoral student in the school of information, University of Michigan.
"You exert more of your agency through an avatar when ...
An anarchic region of star formation
2013-05-02
NGC 6559 is a cloud of gas and dust located at a distance of about 5000 light-years from Earth, in the constellation of Sagittarius (The Archer). The glowing region is a relatively small object, just a few light-years across, in contrast to the one hundred light-years and more spanned by its famous neighbour, the Lagoon Nebula (Messier 8, eso0936 - http://www.eso.org/public/news/eso0936/). Although it is usually overlooked in favour of its distinguished companion, NGC 6559 has the leading role in this new picture.
The gas in the clouds of NGC 6559, mainly hydrogen, is ...
Adult cells transformed into early-stage nerve cells, bypassing the pluripotent stem cell stage
2013-05-02
MADISON, Wis. — A University of Wisconsin-Madison research group has converted skin cells from people and monkeys into a cell that can form a wide variety of nervous-system cells — without passing through the do-it-all stage called the induced pluripotent stem cell, or iPSC.
Bypassing the ultra-flexible iPSC stage was a key advantage, says senior author Su-Chun Zhang, a professor of neuroscience and neurology. "IPSC cells can generate any cell type, which could be a problem for cell-based therapy to repair damage due to disease or injury in the nervous system."
In ...
Gene variant appears to predict weight loss after gastric bypass
2013-05-02
Massachusetts General Hospital (MGH) researchers have identified a gene variant that helps predict how much weight an individual will lose after gastric bypass surgery, a finding with the potential both to guide treatment planning and to facilitate the development of new therapeutic approaches to treating obesity and related conditions like diabetes. The report receiving advance online publication in The American Journal of Human Genetics is the first to identify genetic predictors of weight loss after bariatric surgery.
"We know now that bypass surgery works not by ...
Study confirms everolimus can overcome trastuzumab resistance in HER-2 positive early breast cancer
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.
The study showed a statistically non-significant benefit in clinical response rates for some patients with early breast cancer when everolimus was added to treatment with trastuzumab. Yet the results suggest this benefit is achieved independently of the molecular pathways researchers expected would be involved.
Prof Mario Campone, Principal Investigator ...
Gene expression test distinguishes btw breast cancer patients at high & low risk of late recurrence
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- A test that measures the expression levels of 58 genes in oestrogen receptor-positive breast cancers can effectively differentiate between patients who are at higher and lower risk for having their cancer recur elsewhere in the body more than five years after diagnosis, researchers report.
The new findings show that better individual risk prediction for women with these cancers is getting nearer, says study author Prof Michael Gnant from the Medical University of Vienna, Austria.
Prof Gnant reported the findings at the 5th IMPAKT ...
Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- A new analysis has provided a comprehensive comparison of scores designed to predict which women with oestrogen-receptor positive breast cancer are at high risk of recurrence beyond five years after diagnosis, and may benefit from prolonged endocrine treatment.
The promising new findings will likely benefit the many women with oestrogen-receptor positive breast cancer whose cancer recurs more than five years after diagnosis, researchers told the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
The IMPAKT meeting presents ...
Study reveals magnitude of variation in gene expression measurements within breast cancers
2013-05-02
Lugano-CH, Brussels- BE, 2 May 2013 -- An important new study has revealed the clearest picture yet of precisely how much measurement variation influences gene expression profiles of breast cancer.
The results show, for the first time, which gene expression measurements may benefit from pooling of biopsies from a single tumour, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
These findings represent an important step toward allowing doctors to more precisely tailor an individual's treatment to a detailed analysis of their tumour's gene ...
Study opens new prospects for developing new targeted therapies for breast cancer
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
The IMPAKT meeting presents cutting edge, 'translational' breast cancer research that is beginning to have an impact for patients.
This current study was led by Dr Martine Piccart, Director of Medicine at the Jules ...